Vistra press release ( VST ): Q1 Revenue of $5.64B (+43.5% Y/Y). GAAP first quarter 2026 Net Income of $1,029 million, including an unrealized gain from hedges expected to settle in future years of $723 million, and Ongoing Operations Adjusted EBITDA1 of $1,494 million. Reaffirmed 2026 Ongoing Operations Adjusted EBITDA1 and Ongoing Operations Adjusted FCFbG1 guidance ranges of $6.8 billion to $7....
Vistra press release ( VST ): Q1 Revenue of $5.64B (+43.5% Y/Y). GAAP first quarter 2026 Net Income of $1,029 million, including an unrealized gain from hedges expected to settle in future years of $723 million, and Ongoing Operations Adjusted EBITDA1 of $1,494 million. Reaffirmed 2026 Ongoing Operations Adjusted EBITDA1 and Ongoing Operations Adjusted FCFbG1 guidance ranges of $6.8 billion to $7.6 billion and $3.925 billion to $4.725 billion, respectively. More on Vistra Vistra Is Capitalizing On America's Energy Boom; Growth Will Improve Valuation Sooner Or Later Vistra: Still Not Buying The Dip Here Vistra: Nuclear Deals And AI Demand Support Growth; Risks Remain Vistra Q1 2026 Earnings Preview Quant check: Power stocks in focus as EVs, data center demand drive global electricity surge
"The Pulse With Francine Lacqua" is all about conversations with high profile guests in the beating heart of global business, economics, finance and politics. Based in London, we go wherever the story is, bringing you exclusive interviews and market-moving scoops. Today's guests: James Lord, Morgan Stanley, FX and Emerging Markets Strategy Head; Johann Wadephul, German Foreign Minister. (Source: B...
"The Pulse With Francine Lacqua" is all about conversations with high profile guests in the beating heart of global business, economics, finance and politics. Based in London, we go wherever the story is, bringing you exclusive interviews and market-moving scoops. Today's guests: James Lord, Morgan Stanley, FX and Emerging Markets Strategy Head; Johann Wadephul, German Foreign Minister. (Source: Bloomberg)
Stratasys press release ( SSYS ): Q1 Non-GAAP EPS of -$0.01 beats by $0.01 . Revenue of $132.7M (-2.4% Y/Y) beats by $0.88M . Adjusted EBITDA of $2.0 million, compared to $8.2 million in the prior year period, primarily due to the impact of foreign exchange rates and tariffs Positive operating cash flow of $2.4 million, compared to $4.5 million in the prior year period $237.8 million in cash, equi...
Stratasys press release ( SSYS ): Q1 Non-GAAP EPS of -$0.01 beats by $0.01 . Revenue of $132.7M (-2.4% Y/Y) beats by $0.88M . Adjusted EBITDA of $2.0 million, compared to $8.2 million in the prior year period, primarily due to the impact of foreign exchange rates and tariffs Positive operating cash flow of $2.4 million, compared to $4.5 million in the prior year period $237.8 million in cash, equivalents and short-term deposits and no debt Reiterates 2026 Outlook: Full year revenue growing to a range of $565 million to $575 million vs. $564.48M consensus , improving sequentially through the year. Based on current logistics and materials costs, full year non-GAAP gross margins of 46.7% to 47.1%, including approximately $7 million of adverse impact from tariffs and foreign exchange rates relative to 2025. Full year non-GAAP operating expenses ranging from $260 million to $262 million, including approximately $10 million of adverse impact from changes in foreign exchange rates. Full year non-GAAP operating margins in a range of 0.7% to 1.5%. GAAP net loss of $83 million to $67 million, or ($0.95) to ($0.76) per diluted share. Non-GAAP net income of $8 million to $12.5 million, or $0.09 to $0.14 per diluted share vs. $0.12 consensus. Adjusted EBITDA of $25 million to $30 million, with Adjusted EBITDA margin of 4.5% to 5.0%. Capital expenditures of $20 million to $25 million. Expects to generate positive operating cash flow subject to uncertainty related to foreign exchange rates and tariffs. More on Stratasys Stratasys: Optimism Around Aerospace And Defense Stratasys Q4: Revenue Declines And Profitability Still Eludes Stratasys Ltd. (SSYS) Q4 2025 Earnings Call Transcript Stratasys Q1 2026 Earnings Preview Stratasys outlines $565M–$575M 2026 revenue target as manufacturing and aerospace partnerships expand
Vertex press release ( VERX ): Q1 Non-GAAP EPS of $0.17 beats by $0.01 . Revenue of $196.6M (+11.0% Y/Y) beats by $1.78M . Gross Revenue Retention (“GRR”) was 95%, compared to 95% at March 31, 2025, and 94% at December 31, 2025. Income (loss) from operations of $(10.6) million, compared to $4.5 million for the same period in the prior year. Non-GAAP operating income of $37.6 million, compared to $...
Vertex press release ( VERX ): Q1 Non-GAAP EPS of $0.17 beats by $0.01 . Revenue of $196.6M (+11.0% Y/Y) beats by $1.78M . Gross Revenue Retention (“GRR”) was 95%, compared to 95% at March 31, 2025, and 94% at December 31, 2025. Income (loss) from operations of $(10.6) million, compared to $4.5 million for the same period in the prior year. Non-GAAP operating income of $37.6 million, compared to $31.3 million for the same period in the prior year. Net income (loss) of $(2.5) million, compared to $11.1 million for the same period in the prior year. Net loss per basic and diluted Class A and Class B shares of $0.02, compared to net income per basic and diluted Class A and Class B shares of $0.07 for the same period in the prior year. More on Vertex Vertex, Inc. (VERX) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript Vertex, Inc. (VERX) Q4 2025 Earnings Call Transcript Vertex: Buy At Ultracheap Multiples, Product Is Safe From AI Vertex outlines $823.5M–$831.5M 2026 revenue target as new CEO prioritizes AI-first transformation Vertex Non-GAAP EPS of $0.17, revenue of $194.7M
US equity futures gain and Brent crude falls for a third straight day as the US awaits Iran's response to a proposed deal that would reopen oil flows through the Strait of Hormuz. China advises its largest banks to temporarily suspend new loans to refiners recently sanctioned by the US over their ties to Iranian oil. Sitara Sundar of JPMorgan Private Bank discusses concentration risks in equities ...
US equity futures gain and Brent crude falls for a third straight day as the US awaits Iran's response to a proposed deal that would reopen oil flows through the Strait of Hormuz. China advises its largest banks to temporarily suspend new loans to refiners recently sanctioned by the US over their ties to Iranian oil. Sitara Sundar of JPMorgan Private Bank discusses concentration risks in equities and the Fed's rate path. (Source: Bloomberg)
A new show of this Welsh-born artist’s mesmerising portraits is worth visiting for one nude alone: a painting of an eyes-closed, long-legged, elegant brunette, inspired by Sleeping Venus S ylvia Sleigh wouldn’t paint people if she didn’t find them interesting – and by interesting, I mean attractive. She didn’t idealise nudes like the old masters. Instead, the naked bodies she depicted were really,...
A new show of this Welsh-born artist’s mesmerising portraits is worth visiting for one nude alone: a painting of an eyes-closed, long-legged, elegant brunette, inspired by Sleeping Venus S ylvia Sleigh wouldn’t paint people if she didn’t find them interesting – and by interesting, I mean attractive. She didn’t idealise nudes like the old masters. Instead, the naked bodies she depicted were really, truly beautiful. Many were friends, among them artists and critics. Others were paid models. Scrolling through images of her radical, realist artworks online, I find myself humming along to the REM song: “Shiny happy people …” It was surely part of the appeal of Johanna Lawrenson, the elegant brunette with enviably long legs who posed for the 1963 painting The Bridge. Few exhibitions are worth visiting for a single artwork alone, but this monumental canvas is special. Sleigh kept it until her death in 2010, at which point it was donated to a not-for-profit theatre company in New York. Now it’s for sale, and before it’s snapped up there’s a rare chance to see it on show at Malarkey, a small space overlooking Russell Square in London. Continue reading...
At least three households in Barry identified as having contracted the liver infection Health authorities have asked parents and carers to be “vigilant with their children’s hand-washing” after a hepatitis A outbreak in Barry, south Wales. At least three households in the seaside town have been identified as having contracted the same liver infection, amid worries it is spreading locally, Public H...
At least three households in Barry identified as having contracted the liver infection Health authorities have asked parents and carers to be “vigilant with their children’s hand-washing” after a hepatitis A outbreak in Barry, south Wales. At least three households in the seaside town have been identified as having contracted the same liver infection, amid worries it is spreading locally, Public Health Wales said. Continue reading...
Brian Keith Larabee, senior vice president and general manager of Elastomeric Material Solutions at Rogers Corporation (NYSE:ROG) , reported the sale of 830 shares of common stock for a transaction value of ~$113,000 on May 1, according to a SEC Form 4 filing . Transaction value based on SEC Form 4 reported price ($135.91); post-transaction value based on latest available market close price ($134....
Brian Keith Larabee, senior vice president and general manager of Elastomeric Material Solutions at Rogers Corporation (NYSE:ROG) , reported the sale of 830 shares of common stock for a transaction value of ~$113,000 on May 1, according to a SEC Form 4 filing . Transaction value based on SEC Form 4 reported price ($135.91); post-transaction value based on latest available market close price ($134.44 as of May 1, 2026). 1-year price change calculated using May 1, 2026, as the reference date. Continue reading
Xeris Pharmaceuticals press release ( XERS ): Q1 GAAP EPS of $0.01 beats by $0.02 . Revenue of $82M (+36.4% Y/Y) beats by $2.01M . Selling, general and administrative (SG&A) expenses increased $9.1 million or 21% in the first quarter of 2026 compared to the same period last year. This increase mainly reflects higher personnel related expense to support the commercial enterprise, including the Reco...
Xeris Pharmaceuticals press release ( XERS ): Q1 GAAP EPS of $0.01 beats by $0.02 . Revenue of $82M (+36.4% Y/Y) beats by $2.01M . Selling, general and administrative (SG&A) expenses increased $9.1 million or 21% in the first quarter of 2026 compared to the same period last year. This increase mainly reflects higher personnel related expense to support the commercial enterprise, including the Recorlev expansion. Net income for the first quarter was $2.2 million, compared to a net loss of $9.2 million in the same period last year. Adjusted EBITDA1 for the first quarter was $15.1 million, an improvement of $10.7 million compared to the same period last year. Total Shares Outstanding were 172,642,055 at April 30, 2026. More on Xeris Pharmaceuticals Xeris Biopharma Holdings, Inc. (XERS) Presents at Barclays 28th Annual Global Healthcare Conference Transcript Xeris Biopharma: Undervalued Given The Potential Of Its Drug Portfolio Xeris Biopharma Holdings, Inc. (XERS) Q4 2025 Earnings Call Transcript Xeris Pharmaceuticals Q1 2026 Earnings Preview Xeris rises on 2026 revenue guidance, Q4 top-line beat
Zoetis press release ( ZTS ): Q1 Non-GAAP EPS of $1.53 misses by $0.09. Revenue of $2.3B (+4.5% Y/Y) in-line. Revenue of $2.3 Billion, Growing 3%, and Net Income of $601 Million, or $1.42 per Diluted Share, Flat and Increasing 6%, Respectively, on a Reported Basis Adjusted Net Income of $646 Million, or Adjusted Diluted EPS of $1.53 Flat Organic Operational Growth in Revenue and 1% Organic Operati...
Zoetis press release ( ZTS ): Q1 Non-GAAP EPS of $1.53 misses by $0.09. Revenue of $2.3B (+4.5% Y/Y) in-line. Revenue of $2.3 Billion, Growing 3%, and Net Income of $601 Million, or $1.42 per Diluted Share, Flat and Increasing 6%, Respectively, on a Reported Basis Adjusted Net Income of $646 Million, or Adjusted Diluted EPS of $1.53 Flat Organic Operational Growth in Revenue and 1% Organic Operational Growth in Adjusted Net Income Revises Full Year 2026 Revenue Guidance to $9.680 - $9.960 Billion (vs. consensus of $9.89B) with Organic Operational Revenue Growth of 2% to 5% Revises Full Year 2026 Guidance for Organic Operational Growth in Adjusted Net Income to 2% to 6% Revises Guidance for Diluted EPS on an Adjusted Basis to $6.85 to $7.00 (vs. consensus of $7.03) More on Zoetis IDEXX Laboratories Vs. Zoetis: A Pre-Earnings Comparison Zoetis: Deep Value Persists Zoetis: Still Not Cheap Near 5-Year Lows Zoetis Q1 2026 Earnings Preview Zoetis outlines 3%–5% revenue growth target for 2026 amid competitive pressures and evolving pet care landscape
NORTH BETHESDA, Md., May 07, 2026 (GLOBE NEWSWIRE) -- Xometry, Inc. (NASDAQ: XMTR), the global AI-native marketplace connecting buyers and suppliers of custom manufacturing, today announced its financial results for the first quarter ended March 31, 2026.
NORTH BETHESDA, Md., May 07, 2026 (GLOBE NEWSWIRE) -- Xometry, Inc. (NASDAQ: XMTR), the global AI-native marketplace connecting buyers and suppliers of custom manufacturing, today announced its financial results for the first quarter ended March 31, 2026.
Cloud subscriptions revenue increased 25% year-over-year to $124.5 million, while cash flow provided by operations totaled $48.8 million Cloud subscriptions revenue increased 25% year-over-year to $124.5 million, while cash flow provided by operations totaled $48.8 million
Cloud subscriptions revenue increased 25% year-over-year to $124.5 million, while cash flow provided by operations totaled $48.8 million Cloud subscriptions revenue increased 25% year-over-year to $124.5 million, while cash flow provided by operations totaled $48.8 million
Datadog press release ( DDOG ): Q1 Non-GAAP EPS of $0.60 beats by $0.09 . Revenue of $1.01B (+32.5% Y/Y) beats by $50.06M . Non-GAAP operating income was $223 million; non-GAAP operating margin was 22%. Operating cash flow was $335 million, with free cash flow of $289 million. Cash, cash equivalents, and marketable securities were $4.8 billion as of March 31, 2026. First Quarter & Recent Business ...
Datadog press release ( DDOG ): Q1 Non-GAAP EPS of $0.60 beats by $0.09 . Revenue of $1.01B (+32.5% Y/Y) beats by $50.06M . Non-GAAP operating income was $223 million; non-GAAP operating margin was 22%. Operating cash flow was $335 million, with free cash flow of $289 million. Cash, cash equivalents, and marketable securities were $4.8 billion as of March 31, 2026. First Quarter & Recent Business Highlights: As of March 31, 2026, we had about 4,550 customers with ARR of $100,000 or more, an increase of 21% from about 3,770 as of March 31, 2025. Second Quarter and Full Year 2026 Outlook: Based on information as of today, May 7, 2026, Datadog is providing the following guidance: Second Quarter 2026 Outlook: Revenue between $1.07 billion and $1.08 billion vs. $994.47M consensus. Non-GAAP operating income between $225 million and $235 million. Non-GAAP net income per share between $0.57 and $0.59 vs. $0.50 consensus , assuming approximately 369 million weighted average diluted shares outstanding. Full Year 2026 Outlook: Revenue between $4.30 billion and $4.34 billion vs. $4.12B consensus (prior $4.06 billion and $4.10 billion). Non-GAAP operating income between $940 million and $980 million. Non-GAAP net income per share between $2.36 and $2.44 vs. $2.18 consensus (prior $2.08 and $2.16) , assuming approximately 372 million weighted average diluted shares outstanding. More on Datadog Datadog: AI Complexity Turning It Into A Must-Have Platform Datadog: Essential Infrastructure For Modern Technology Stacks Datadog Is A Buy: Why The SaaSpocalypse Doesn't Apply Here Datadog secures FedRAMP High certification for government cloud platform Datadog Q1 2026 Earnings Preview
The majority shareholder of Shenzhen-listed Wuliangye Yibin (Wuliangye) – China’s iconic premium baijiu producer – plans to increase its equity stake in the listed unit by purchasing between 3 billion yuan (US$441 million) and 5 billion yuan worth of shares over the next six months, in a move aimed at bolstering investor confidence after the stock slid to a six-year low. Analysts said the stake in...
The majority shareholder of Shenzhen-listed Wuliangye Yibin (Wuliangye) – China’s iconic premium baijiu producer – plans to increase its equity stake in the listed unit by purchasing between 3 billion yuan (US$441 million) and 5 billion yuan worth of shares over the next six months, in a move aimed at bolstering investor confidence after the stock slid to a six-year low. Analysts said the stake increase followed a prolonged downturn in China’s baijiu sector and growing unease among investors...
N-able press release ( NABL ): Q1 Non-GAAP EPS of $0.09 in-line. Revenue of $133.7M (+13.1% Y/Y) beats by $2.08M . As of March 31, 2026, total cash and cash equivalents were $117.8M, and total debt, net of debt issuance costs, was $393.1M. More on N-able N-able, Inc. (NABL) Q4 2025 Earnings Call Transcript Google Cloud partners with Thoma Bravo to advance AI adoption by enterprises N-able targets ...
N-able press release ( NABL ): Q1 Non-GAAP EPS of $0.09 in-line. Revenue of $133.7M (+13.1% Y/Y) beats by $2.08M . As of March 31, 2026, total cash and cash equivalents were $117.8M, and total debt, net of debt issuance costs, was $393.1M. More on N-able N-able, Inc. (NABL) Q4 2025 Earnings Call Transcript Google Cloud partners with Thoma Bravo to advance AI adoption by enterprises N-able targets $581M to $586M ARR in 2026 as AI-driven cybersecurity momentum builds Seeking Alpha’s Quant Rating on N-able Historical earnings data for N-able